Saxenda® (Liraglutide Injection) – 0.6 mg | 1.2 mg | 1.8 mg

Saxenda® (Liraglutide Injection) is a prescription GLP-1 receptor agonist indicated for chronic weight managementin adults with obesity or overweight conditions associated with metabolic risk factors. It works by regulating appetite centers in the brain, helping reduce hunger and calorie intake.

Saxenda is clinically proven and widely prescribed worldwide for sustainable weight loss when used alongside a reduced-calorie diet and increased physical activity. It is administered as a once-daily subcutaneous injection using a prefilled pen.

Available strengths include 0.6 mg, 1.2 mg, and 1.8 mg, allowing gradual dose escalation as recommended by healthcare professionals.

Medicina Overseas supplies Saxenda® Injection for international markets, supporting pharmacies, clinics, hospitals, and bulk buyers with reliable sourcing, export packaging, and regulatory-ready documentation.

⚠️ Prescription medicine. Use only under medical supervision.

✅ KEY BENEFITS (HIGH CONVERSION SECTION)

• Supports effective appetite control

• Clinically proven for weight management

• Once-daily injectable therapy

• Trusted global brand by Novo Nordisk

• Suitable for long-term obesity treatment plans